Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BVS | TBPH | SPRY | ||
| Company | Bioventus Inc Cl A | Theravance Bio Ord | Ars Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 9.72 | 16.58 | 7.82 | ||
| High | 9.87 | 16.82 | 8.26 | ||
| Low | 9.61 | 16.53 | 7.72 | ||
| Latest | 9.87 | 16.74 | 8.26 | ||
| Change | +0.20 | +0.07 | +0.42 | ||
| % Change | +2.07% | +0.42% | +5.36% | ||
| Volume | 297,094 | 263,938 | 1,357,202 | ||
| 20-Day Average Volume | 446,355 | 379,567 | 1,540,105 | ||
| Previous Close | 9.67 | 16.67 | 7.84 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 9.70 | 16.58 | 8.14 | ||
| 20-Day Raw Stochastic | 56.80% | 66.89% | 67.03% | ||
| 20-Day Relative Strength | 56.13 | 53.41 | 48.64 | ||
| Weighted Alpha | +46.50 | +60.79 | -45.82 | ||
| Today's Opinion | 100% Buy | 24% Buy | 88% Sell | ||
| Previous Opinion | 100% Buy | 24% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 24% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.65% since 04/23/26 | +2.64% since 04/23/26 | -0.48% since 04/23/26 | ||
| Low | 9.56 on 04/29/26 | 16.14 on 04/24/26 | 7.65 on 04/29/26 | ||
| High | 10.30 on 04/28/26 | 16.99 on 04/28/26 | 8.45 on 04/27/26 | ||
| 1-Month | |||||
| %Chg | +10.16% since 03/30/26 | +9.70% since 03/30/26 | +5.69% since 03/30/26 | ||
| Low | 8.64 on 03/31/26 | 15.38 on 03/31/26 | 7.65 on 04/29/26 | ||
| High | 10.76 on 04/17/26 | 17.24 on 04/17/26 | 8.56 on 04/22/26 | ||
| 3-Month | |||||
| %Chg | +24.46% since 01/30/26 | -11.62% since 01/30/26 | -17.32% since 01/30/26 | ||
| Low | 7.78 on 02/11/26 | 13.08 on 03/03/26 | 7.20 on 03/24/26 | ||
| High | 10.76 on 04/17/26 | 20.60 on 02/09/26 | 10.74 on 02/03/26 | ||
| 6-Month | |||||
| %Chg | +45.79% since 10/30/25 | +17.06% since 10/30/25 | -4.18% since 10/30/25 | ||
| Low | 6.47 on 11/21/25 | 13.08 on 03/03/26 | 6.66 on 11/21/25 | ||
| High | 10.76 on 04/17/26 | 21.03 on 01/22/26 | 13.15 on 01/12/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 804,109 | 858,388 | 778,488 | ||
| Shares Outstanding, K | 83,155 | 51,493 | 99,297 | ||
| Annual Sales | 568,090,000 | 107,460,000 | 84,280,000 | ||
| Annual Net Income | 22,730,000 | 105,900,000 | -171,300,000 | ||
| Last Quarter Sales | 157,900,000 | 45,890,000 | 28,090,000 | ||
| Last Quarter Net Income | 14,760,000 | 61,020,000 | -41,320,000 | ||
| 60-Month Beta | 0.70 | 0.17 | 0.86 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.24 on 03/05/26 | 0.06 on 03/19/26 | -0.42 on 03/09/26 | ||
| Earnings Date | 05/05/26 | 05/14/26 | 05/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 14.65 | 22.35 | 0.00 | ||